Healthcare Economist August 6, 2024
Jason Shafrin

Perhaps not. At least that is according to a paper by Anderson et al. (2024). The authors use a difference-in-difference approach with 2018-2021 claims data. A summary of the results are below.

Approximately one-quarter of patients who use insulin report underuse because of cost. In response, more than twenty states have implemented monthly caps on insulin out-of-pocket spending, ranging from $25 to $100…
State-level caps on insulin out-of-pocket spending for commercial enrollees did not significantly increase insulin use; that may be in part...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Insurance, Patient / Consumer, Provider, States
Montana’s Medicaid Expansion Conundrum
Per capita spending on health care: 13 states at the bottom
California's regulatory roadblocks: The policies limiting ASC expansion
The market dynamics shaping the state with the most ASCs
Health care spending per person: 12 states where it is highest — a slideshow

Share This Article